How selegiline ((-)-deprenyl) slows brain aging

Research output: Book/ReportBook

5 Citations (Scopus)


Deprenyl, developed in the early 1960s with the aim to combine the psychostimulant effect of PEA with the psychoenergetic effect of the MAO inhibitors, became world-wide known and used as the first selective inhibitor of B-type MAO, which did not block the activity of the intestinal A-type MAO, thus was free from the cheese-effect.

Original languageEnglish
PublisherBentham Science Publishers Ltd.
ISBN (Print)9781608055944
Publication statusPublished - Dec 1 2012

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'How selegiline ((-)-deprenyl) slows brain aging'. Together they form a unique fingerprint.

  • Cite this